Sea Mild Biotechnology Co., Ltd. announced earnings results for the full year ended December 31, 2019. For the full year, the company announced sales was TWD 214.141 million compared to TWD 215.072 million a year ago. Operating loss was TWD 142.844 million compared to TWD 7.602 million a year ago. Net loss was TWD 159.125 million compared to net income of TWD 66,000 a year ago. Basic loss per share was TWD 6.41.